First Trust Advisors LP Has $2.48 Million Position in Merit Medical Systems, Inc. $MMSI

First Trust Advisors LP raised its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 479.1% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 35,907 shares of the medical instruments supplier’s stock after acquiring an additional 29,706 shares during the quarter. First Trust Advisors LP owned about 0.06% of Merit Medical Systems worth $2,475,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP increased its holdings in Merit Medical Systems by 377.7% in the third quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock valued at $103,248,000 after purchasing an additional 980,823 shares during the last quarter. Norges Bank acquired a new position in shares of Merit Medical Systems during the 4th quarter worth about $75,957,000. Iron Triangle Partners LP acquired a new position in shares of Merit Medical Systems during the 4th quarter worth about $33,992,000. Champlain Investment Partners LLC bought a new stake in shares of Merit Medical Systems in the 4th quarter valued at about $32,359,000. Finally, Fifth Third Bancorp raised its position in shares of Merit Medical Systems by 24,625.6% in the 1st quarter. Fifth Third Bancorp now owns 313,026 shares of the medical instruments supplier’s stock valued at $21,577,000 after acquiring an additional 311,760 shares during the period. Institutional investors own 99.66% of the company’s stock.

Wall Street Analyst Weigh In

MMSI has been the subject of a number of analyst reports. Robert W. Baird set a $98.00 price objective on shares of Merit Medical Systems in a report on Friday, July 31st. Needham & Company LLC lifted their price target on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Compass Point set a $107.00 price objective on Merit Medical Systems in a research note on Monday, April 20th. Wells Fargo & Company raised their price target on Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, Raymond James Financial restated an “outperform” rating and set a $100.00 target price on shares of Merit Medical Systems in a report on Friday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $100.30.

Merit Medical Systems Stock Up 1.5%

NASDAQ:MMSI opened at $89.04 on Friday. The stock has a 50-day simple moving average of $72.21 and a 200 day simple moving average of $71.97. Merit Medical Systems, Inc. has a 52-week low of $59.74 and a 52-week high of $94.75. The company has a market cap of $5.32 billion, a PE ratio of 36.79, a PEG ratio of 2.21 and a beta of 0.49. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, beating the consensus estimate of $0.96 by $0.23. The firm had revenue of $418.84 million for the quarter, compared to analysts’ expectations of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, sell-side analysts expect that Merit Medical Systems, Inc. will post 3.81 EPS for the current fiscal year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.